Bed, Bath and Beyond 2012 Annual Report Download - page 67

Download and view the complete annual report

Please find page 67 of the 2012 Bed, Bath and Beyond annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 76

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END
The following table sets forth information for each of the named executive officers with respect to the value of all unexercised
options and unvested restricted stock awards as of March 2, 2013, the end of fiscal 2012.
Option Awards Stock Awards
Name
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable
Option
Exercise
Price
($)
Option
Expiration
Date
Number of
Shares or
Units of
Stock That
Have Not
Vested
(#)
Market Value
of Shares
or Units of
Stock That
Have Not
Vested
(2)
($)
Warren Eisenberg 100,000 — $38.5150 4/17/14 103,448
(6)
$ 5,889,295
100,000 — $41.1150 5/10/15
81,367 — $32.8700 5/12/16
84,603 — $28.3300 5/11/17
19,551 9,775
(3)
$45.2000 5/10/18
8,480 16,960
(3)
$56.1850 5/10/19
— 21,682
(3)
$68.9100 5/10/20
Leonard Feinstein 100,000 — $38.5150 4/17/14 103,448
(6)
$ 5,889,295
100,000 — $41.1150 5/10/15
81,367 — $32.8700 5/12/16
84,603 — $28.3300 5/11/17
19,551 9,775
(3)
$45.2000 5/10/18
8,480 16,960
(3)
$56.1850 5/10/19
— 21,682
(3)
$68.9100 5/10/20
Steven H. Temares 300,000
(10)
— $41.3450 3/03/14 285,224
(7)
$16,237,802
259,886
(1)
— $38.7650 4/25/13
200,000
(10)
— $38.5150 4/17/14
200,000 — $41.1150 5/10/15
299,430
(10)
74,858
(4)
$32.8700 5/12/16
177,665 118,444
(4)
$28.3300 5/11/17
105,572 158,358
(4)
$45.2000 5/10/18
50,880 203,520
(4)
$56.1850 5/10/19
— 249,347
(4)
$68.9100 5/10/20
Arthur Stark 5,000 5,000
(5)
$38.7950 4/17/14 129,613
(8)
$ 7,378,868
5,000 10,000
(5)
$41.1150 5/10/15
8,206 24,618
(5)
$32.8700 5/12/16
8,932 35,732
(5)
$28.3300 5/11/17
12,840 19,261
(5)
$45.2000 5/10/18
6,105 24,423
(5)
$56.1850 5/10/19
— 26,019
(5)
$68.9100 5/10/20
Eugene A. Castagna 100,000 — $41.3450 3/03/14 101,170
(9)
$ 5,759,608
20,000 5,000
(5)
$38.7950 4/17/14
15,000 10,000
(5)
$41.1150 5/10/15
16,411 24,618
(5)
$32.8700 5/12/16
8,932 35,732
(5)
$28.3300 5/11/17
12,840 19,261
(5)
$45.2000 5/10/18
6,105 24,423
(5)
$56.1850 5/10/19
— 26,019
(5)
$68.9100 5/10/20
(1) These options represent a portion of Mr. Temares’ April 25, 2003 grant, the exercise price of which was increased in order to comply
with Section 409A of the Code following the Company’s 2006 review of its equity grants and procedures.
(2) Market value is based on the closing price of the Company’s common stock of $56.93 per share on March 1, 2013, the last trading
day in fiscal 2012.
(3) Messrs. Eisenberg and Feinstein’s unvested option awards are scheduled to vest as follows: (a) 9,775 on May 10, 2013, (b) 8,480 on
each of May 10, 2013 and 2014, and (c) 7,228 on May 10, 2013 and 7,227 on each of May 10, 2014 and 2015.
(4) Mr. Temares’ unvested option awards are scheduled to vest as follows: (a) 74,858 on May 12, 2013, (b) 59,222 on each of May 11,
2013 and 2014, (c) 52,786 on each of May 10, 2013, 2014 and 2015, (d) 50,880 on each of May 10, 2013, 2014, 2015 and 2016, and
(e) 49,869 on each of May 10, 2013, 2014 and 2016 and 49,870 on each of May 10, 2015 and 2017.
BED BATH & BEYOND PROXY STATEMENT
65